1. Home
  2. FLEX vs ILMN Comparison

FLEX vs ILMN Comparison

Compare FLEX & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flex Ltd.

FLEX

Flex Ltd.

SELL

Current Price

$101.00

Market Cap

43.9B

Sector

Technology

ML Signal

SELL

Logo Illumina Inc.

ILMN

Illumina Inc.

SELL

Current Price

$270.17

Market Cap

37.0B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
FLEX
ILMN
Founded
1990
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.9B
37.0B
IPO Year
1997
2000

Fundamental Metrics

Financial Performance
Metric
FLEX
ILMN
Price
$101.00
$270.17
Analyst Decision
Strong Buy
Buy
Analyst Count
11
21
Target Price
$160.50
★ $236.55
AVG Volume (30 Days)
2.9M
★ 3.7M
Earning Date
10-28-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
10.43
★ 170.87
EPS
0.76
★ 2.22
Revenue
★ $28,679,925,000.00
$4,343,000,000.00
Revenue This Year
$24.03
$6.48
Revenue Next Year
$29.92
$6.46
P/E Ratio
$145.89
★ $122.15
Revenue Growth
★ 18.95
N/A
52 Week Low
$53.07
$93.50
52 Week High
$166.86
$309.35

Technical Indicators

Market Signals
Indicator
FLEX
ILMN
Relative Strength Index (RSI) 35.95 59.26
Support Level $58.92 $116.43
Resistance Level $119.11 $309.35
Average True Range (ATR) 5.35 13.63
MACD -0.85 -1.80
Stochastic Oscillator 4.59 32.47

Price Performance

Historical Comparison
FLEX
ILMN

About FLEX Flex Ltd.

Flex Ltd is the developed, end-to-end manufacturing partner of choice that helps a diverse customer base design, build, deliver and manage products that improve the world. The Company's full suite of specialized capabilities includes design and engineering, supply chain, manufacturing, and integrated services, plus a portfolio of power and cooling products. Its reportable segments includes Integrated Technology Solutions, Regulated Manufacturing Solutions, and Cloud and Power Infrastructure.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: